Last 45 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has compressed 23.9% YoY to 12.9x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -23.85 | — | — | — | — | — | — | — | — | — | — | 25.22 | 74.98 |
| — | — | — | — | — | — | — | — | — | — | — | — | +76.3% | |
| P/S Ratio | 0.58 | 0.47 | 0.56 | 0.84 | 0.85 | 0.97 | 0.77 | 1.32 | 0.98 | 1.31 | 1.37 | 1.36 | 2.15 |
| — | -51.3% | -28.2% | -36.7% | -13.2% | -26.0% | -43.5% | -3.2% | -54.1% | -19.1% | +36.3% | +62.8% | +105.5% | |
| P/B Ratio | 0.52 | 0.44 | 0.56 | 0.77 | 0.79 | 0.84 | 0.73 | 1.15 | 0.83 | 1.12 | 1.20 | 1.11 | 1.73 |
| — | -47.6% | -24.2% | -32.6% | -4.9% | -25.0% | -38.6% | +3.4% | -52.1% | -14.8% | +38.4% | +30.2% | +60.4% | |
| P/FCF | 9.73 | — | 5.42 | 10.76 | 12.19 | — | 7.50 | 22.60 | 13.42 | 47.69 | 23.50 | 10.73 | 54.47 |
| — | — | -27.7% | -52.4% | -9.2% | — | -68.1% | +110.6% | -75.4% | +121.9% | — | -74.4% | +67.0% | |
| EV / EBITDA | 10.06 | 12.89 | 8.45 | 11.04 | 10.61 | 16.94 | 9.48 | 16.57 | 12.99 | 15.34 | 13.00 | 14.45 | 17.32 |
| — | -23.9% | -10.9% | -33.4% | -18.3% | +10.4% | -27.1% | +14.7% | -25.0% | -29.5% | +17.3% | +9.3% | +26.2% | |
| EV / EBIT | 14.60 | — | 6.11 | 4.38 | 14.44 | 26.87 | 12.01 | 30.24 | 18.33 | 22.14 | 16.99 | 19.50 | 21.65 |
| — | — | -49.1% | -85.5% | -21.2% | +21.3% | -29.3% | +55.0% | -15.4% | -41.0% | +16.7% | +5.2% | +15.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Surgery Partners, Inc.'s operating margin was 8.1% in Q1 2026, down 4.3 pp QoQ and up 0.1 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 11.7% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 5.3% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.1% | 19.8% | 24.0% | 23.8% | 23.7% | 20.9% | 27.0% | 23.0% | 23.5% | 21.6% | 26.3% | 24.6% | 23.1% |
| — | -5.3% | -11.3% | +3.2% | +0.7% | -3.6% | +2.7% | -6.3% | +1.9% | +7.6% | +1.0% | +16.3% | +5.5% | |
| Operating Margin | 11.8% | 8.1% | 12.5% | 12.9% | 13.5% | 8.0% | 14.7% | 7.9% | 11.1% | 10.6% | 13.8% | 12.3% | 14.6% |
| — | +1.7% | -15.3% | +62.8% | +21.5% | -24.7% | +6.6% | -35.5% | -23.9% | +52.1% | +3.5% | +2.6% | +17.6% | |
| Net Margin | -2.4% | -4.4% | -1.7% | -2.8% | -0.3% | -4.9% | -12.6% | -4.1% | -2.0% | -1.7% | -0.1% | -0.7% | 2.8% |
| — | +8.9% | +86.5% | +32.8% | +85.1% | -181.1% | -9129.5% | -466.1% | -171.8% | +53.8% | +95.9% | +82.0% | +194.7% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.2% | -1.0% | -0.4% | -0.6% | -0.1% | -1.0% | -3.0% | -0.9% | -0.4% | -0.4% | -0.0% | -0.1% | 0.6% |
| — | +1.9% | +86.0% | +28.0% | +84.3% | -183.0% | -10003.0% | -498.5% | -177.5% | +51.3% | +96.3% | +85.7% | +173.7% | |
| ROA | -1.0% | -0.4% | -0.2% | -0.3% | -0.0% | -0.5% | -1.4% | -0.4% | -0.2% | -0.2% | -0.0% | -0.1% | 0.3% |
| — | +7.4% | +86.8% | +32.3% | +85.3% | -165.9% | -9536.3% | -477.3% | -175.2% | +52.1% | +95.9% | +81.2% | +197.4% | |
| ROIC | 4.1% | 0.7% | 1.1% | 1.1% | 1.2% | 0.6% | 1.4% | 0.7% | 1.0% | 0.9% | 1.2% | 1.0% | 1.2% |
| — | +3.9% | -17.0% | +64.6% | +20.1% | -28.5% | +10.9% | -34.7% | -21.0% | +54.8% | +3.1% | +4.9% | +16.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Surgery Partners, Inc.'s Debt/EBITDA ratio is 38.6x, up from 23.7x last quarter — elevated, raising questions about debt serviceability. Debt/Equity has risen for 12 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.14 | 1.16 | 1.14 | 1.09 | 1.08 | 1.08 | 1.02 | 0.99 | 0.95 | 0.94 | 0.91 | 0.90 | 0.88 |
| — | +7.1% | +12.0% | +9.9% | +14.4% | +15.0% | +11.9% | +9.6% | +8.2% | +6.5% | +2.0% | -38.1% | -38.5% | |
| Debt / EBITDA | 7.12 | 38.62 | 23.66 | 26.66 | 25.52 | 39.46 | 23.00 | 31.68 | 28.67 | 28.80 | 23.11 | 26.93 | 23.77 |
| — | -2.1% | +2.9% | -15.8% | -11.0% | +37.0% | -0.4% | +17.6% | +20.6% | -20.5% | -2.4% | -21.6% | -26.8% | |
| Current Ratio | 1.87 | 1.86 | 1.87 | 1.88 | 1.93 | 1.89 | 1.79 | 1.80 | 1.83 | 1.71 | 1.71 | 1.75 | 1.77 |
| — | -1.4% | +4.3% | +4.4% | +5.1% | +10.3% | +4.8% | +3.0% | +3.9% | -6.4% | -8.3% | +47.8% | +16.9% | |
| Quick Ratio | 1.71 | 1.69 | 1.71 | 1.72 | 1.78 | 1.73 | 1.65 | 1.66 | 1.69 | 1.56 | 1.57 | 1.61 | 1.61 |
| — | -2.6% | +3.7% | +3.9% | +5.2% | +10.7% | +5.3% | +3.1% | +4.6% | -6.7% | -9.0% | +50.0% | +16.2% | |
| Interest Coverage | 1.43 | 0.95 | 1.22 | 1.09 | 1.65 | 1.00 | 2.40 | 1.22 | 1.65 | 1.61 | 2.08 | 1.66 | 2.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 45 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SGRY stock.
Surgery Partners, Inc.'s current P/E is -23.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Surgery Partners, Inc.'s current operating margin is 11.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Surgery Partners, Inc.'s business trajectory between earnings reports.